Flu Vaccine Effective for 2022/2023 Season

MONDAY, Feb. 27, 2023 (HealthDay News) -- During the 2022 to 2023 influenza season, vaccination is effective for reducing the risk for medically attended influenza among children and adults aged younger than 65 years and for symptomatic influenza among children, according to research published in the Feb. 24 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Huong Q. McLean, Ph.D., from the Marshfield Clinic Research Institute in Wisconsin, and colleagues used data from two concurrent studies conducted in Wisconsin during Oct. 23, 2022, to Feb. 10, 2023, to estimate influenza vaccine effectiveness (VE).
The researchers found that among patients aged 6 months to 64 years, VE was 54 percent against medically attended outpatient acute respiratory illness associated with influenza A. VE was 71 percent against symptomatic influenza A virus infection in a community cohort of children aged younger than 18 years.
"During the 2022-23 season to date, influenza A viruses that predominated are genetically and antigenically similar to current vaccine components," the authors write. "Influenza vaccination is recommended for all persons aged ≥6 months for as long as influenza viruses are circulating in the community."
Several authors disclosed financial ties to the biopharmaceutical industry.
Related Posts
Recibir la vacuna contra COVID durante el embarazo ayuda a proteger a los recién nacidos, según un estudio de los CDC
LUNES, 2 de octubre de 2023 (HealthDay News) – Cuando las mujeres embarazadas...
Number of U.S. Births Increased in Second Half of 2021
TUESDAY, July 19, 2022 (HealthDay News) -- The number of births across the...
Otro beneficio del deporte para los niños: unos ojos más sanos
JUEVES, 6 de octubre de 2022 (HealthDay News) -- A veces, las alergias pueden...
Worries May Raise Men’s Heart Risks, Even When Young
MONDAY, Jan. 24, 2022 (HealthDay News) -- Worrying can take a toll on your...